Wordt geladen...
Immunotherapy for Non-Small Cell Lung Cancer
Lung cancer is the leading cause of cancer-related mortality worldwide, and more than 80% of cases are of non-small cell lung cancer. Although chemotherapy and molecularly targeted therapy may provide some benefit, there is a need for newer therapies for the treatment of patients with advanced NSCLC...
Bewaard in:
| Hoofdauteur: | |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
The Korean Academy of Tuberculosis and Respiratory Diseases
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4192308/ https://ncbi.nlm.nih.gov/pubmed/25309605 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4046/trd.2014.77.3.111 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|